Therefore, our study aimed to explore the value of SGLT1 for the diagnosis of DCM, and the cardioprotective effect of SGLT1 inhibition on DCM development via JNK and P38 pathway. This evidence concerns the gene MAPK8 and familial dilated cardiomyopathy.